MARKET

VNRX

VNRX

Volitionrx
AMEX
0.2267
-0.0085
-3.61%
After Hours: 0.2254 -0.0013 -0.57% 19:52 02/13 EST
OPEN
0.2327
PREV CLOSE
0.2352
HIGH
0.2327
LOW
0.2111
VOLUME
1.33M
TURNOVER
--
52 WEEK HIGH
0.9400
52 WEEK LOW
0.2111
MARKET CAP
30.73M
P/E (TTM)
-0.9900
1D
5D
1M
3M
1Y
5Y
1D
Volition Announces the Appointment of New Distributor for Nu.Q® Discover
PR Newswire · 3d ago
VolitionRx receives NYSE non-compliance notice
Seeking Alpha · 4d ago
VolitionRx files to sell 17.97M shares of common stock for holders
TipRanks · 4d ago
Weekly Report: what happened at VNRX last week (0202-0206)?
Weekly Report · 5d ago
VolitionRx To Highlight NETs Plasma Biomarker In Precision Medicine At EHSF Malta Conference
Benzinga · 02/04 13:51
Volition Sponsors Symposium at 15th Conference of the European Hidradenitis Suppurativa Foundation
PR Newswire · 02/04 13:45
Weekly Report: what happened at VNRX last week (0126-0130)?
Weekly Report · 02/02 09:21
VolitionRx preparing reimbursement submission for Nu.Q cancer assays in France
TipRanks · 01/30 13:55
More
About VNRX
VolitionRx Limited is a multi-national company focused on advancing the science of epigenetics. The Company is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and monitor a range of diseases, including cancers and diseases associated with NETosis, such as sepsis. Its key pillars are Nu.Q Vet, Nu.Q NETs, Nu.Q Discover, Nu.Q Cancer, and Capture-PCR. The Nu.Q Vet Cancer Test is commercially available as a cancer screening test in dogs. Nu.Q NETs is monitoring the immune system to save lives. Nu.Q Discover is a complete solution to profiling nucleosomes. Nu.Q Cancer monitoring disease progression, response to treatment and minimal residual disease. Capture-PCRTM is isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection.

Webull offers VolitionRX Ltd stock information, including AMEX: VNRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VNRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VNRX stock methods without spending real money on the virtual paper trading platform.